000020 — Dongwha Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual cashflow statement for Dongwha Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	28,715	19,583	21,591	28,237	2,146
Depreciation
Amortisation
Non-Cash Items	4,028	16,235	19,006	914	22,489
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	8,778	-11,880	-23,886	-13,880	-48,307
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	52,228	36,031	29,221	29,167	-4,003
Capital Expenditures	-30,115	-24,774	-20,091	-26,346	-74,064
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4,284	-640	-23,181	29,209	-725
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-25,831	-25,414	-43,272	2,863	-74,789
Financing Cash Flow Items	—	—	—	—	-5.55
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5,458	-8,783	-12,013	5,866	31,356
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	20,817	1,883	-26,133	37,970	-46,661